These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Strength training and aerobic exercise training for muscle disease. Voet NB; van der Kooi EL; Riphagen II; Lindeman E; van Engelen BG; Geurts AC Cochrane Database Syst Rev; 2013 Jul; (7):CD003907. PubMed ID: 23835682 [TBL] [Abstract][Full Text] [Related]
25. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858 [TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin for the treatment of childhood encephalitis. Iro MA; Martin NG; Absoud M; Pollard AJ Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological treatment for pain in Guillain-Barré syndrome. Liu J; Wang LN; McNicol ED Cochrane Database Syst Rev; 2013 Oct; (10):CD009950. PubMed ID: 24142399 [TBL] [Abstract][Full Text] [Related]
28. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Dalakas MC Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Hughes RA; Pritchard J; Hadden RD Cochrane Database Syst Rev; 2013 Feb; (2):CD008630. PubMed ID: 23450584 [TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Van Schaik IN; Winer JB; De Haan R; Vermeulen M Cochrane Database Syst Rev; 2002; (2):CD001797. PubMed ID: 12076423 [TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031 [TBL] [Abstract][Full Text] [Related]
33. Interventions for Old World cutaneous leishmaniasis. Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474 [TBL] [Abstract][Full Text] [Related]
34. Strength training and aerobic exercise training for muscle disease. Voet NB; van der Kooi EL; van Engelen BG; Geurts AC Cochrane Database Syst Rev; 2019 Dec; 12(12):CD003907. PubMed ID: 31808555 [TBL] [Abstract][Full Text] [Related]
35. Treatment for IgG and IgA paraproteinaemic neuropathy. Stork AC; Lunn MP; Nobile-Orazio E; Notermans NC Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD005376. PubMed ID: 25803231 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003217. PubMed ID: 25739040 [TBL] [Abstract][Full Text] [Related]